Antiserum
Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue.
Aromatase inhibitors have been broadly used for the endocrine therapy of estrogen-dependent breast cancer in postmenopausal sufferers. However, clinicopathological research of aromatase have been restricted due to unsatisfactory specificity and/or restricted availability of anti-aromatase antibodies. Here, we have now generated Read more…